Dis-Chem announced a 10.1% increase in group revenue for the past 24 weeks following the launch of its Better Rewards Programme in October last year, reported Business Day (23 Feb 2026) “The previous loyalty model has been replaced with a data-led system that integrates rewards across retail purchases, clinic visits and financial services. Dis-Chem positions this as part of a broader shift beyond traditional pharmacy retail towards an integrated healthcare business model. The aim is to make access to healthcare services cheaper and easier for customers.”
Pharmaceuticals Made in SA (Pharmisa) is demanding that the National Department of Health (NDoH) include domestic producers in the next major medicine tenders. – Business Day (23 Feb 2026)
In a letter delivered to the Board of the Government Employees Medical Scheme’s (GEMS) trade unions in the Public Service Co-ordinating Bargaining Council (PSCBC) rejected the scheme’s 9.8% tariff increase. The union also demanded the immediate removal of principal officer Dr Stanley Moloabi and the scheme’s executive leadership as well as a forensic audit into governance, finances, procurement practice, and administrative expenditure. – Times Live (17 Feb 2026) Business Day (23 Feb 2026)
In a letter from the Office of State Attorney (20 Feb 2026) President Cyril Ramaphosa formally announced that no part of NHI Act will be put into operation until the Constitutional Court (ConCourt) has ruled on two challenges focused on public participation. – Business Day 2026